Krystal Biotech Inc (KRYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 344,865 | 373,966 | 345,786 | 359,006 | 358,328 |
| Marketable Securities | 252,652 | 214,358 | 213,826 | 179,253 | 173,850 |
| Receivables | 104,746 | 97,298 | 103,236 | 46,467 | 42,040 |
| Inventories | 26,508 | 18,581 | 12,179 | 11,037 | 6,985 |
| Income taxes - deferred | 1,617 | N/A | N/A | N/A | N/A |
| TOTAL | $742,045 | $713,164 | $682,772 | $602,248 | $587,909 |
| Non-Current Assets | |||||
| PPE Net | 155,168 | 156,592 | 158,808 | 160,011 | 161,202 |
| Investments And Advances | 152,114 | 105,888 | 69,292 | 83,996 | 61,954 |
| Other Non-Current Assets | 6,511 | 6,674 | 6,786 | 7,041 | 7,290 |
| TOTAL | $313,793 | $269,154 | $234,886 | $251,048 | $230,446 |
| Total Assets | $1,055,838 | $982,318 | $917,658 | $853,296 | $818,355 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,985 | 5,580 | 5,425 | 5,359 | 4,132 |
| Accrued Expenses | 95,793 | 82,655 | 65,065 | 40,800 | 27,488 |
| TOTAL | $101,995 | $89,527 | $71,851 | $47,589 | $33,094 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 7,463 | 6,945 | 6,914 | 6,465 | 6,620 |
| TOTAL | $7,463 | $6,945 | $6,914 | $6,465 | $6,620 |
| Total Liabilities | $109,458 | $96,472 | $78,765 | $54,054 | $39,714 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,806 | 28,761 | 28,730 | 28,558 | 28,293 |
| Retained earnings | -180,668 | -226,147 | -253,327 | -268,895 | -269,827 |
| Other shareholders' equity | -190 | 1,512 | -634 | -299 | 638 |
| TOTAL | $946,380 | $885,846 | $838,893 | $799,242 | $778,641 |
| Total Liabilities And Equity | $1,055,838 | $982,318 | $917,658 | $853,296 | $818,355 |